Welnox Enters into a Licensing Partnership with P&G for Vicks VapoRub

Welnox, a Martin Dow Group firm, unveiled that it has entered into a licensing partnership with Procter & Gamble (P&G) for Vicks VapoRub, with availability projected to commence in the coming weeks.

Key points

• Add ProPakistani to Preferred Sources and see more of our stories in Google Search and Top Stories.
• Add as a preferredSource on Google Follow on Google News Join WhatsApp.
• This strategic partnership reinforces Martin Dow's commitment to expand access to high-quality, reliable healthcare solutions for millions of consumers nationwide.
• Anwar Zaman, CEO, Welnox, remarked, Vicks VapoRub is an iconic brand with enduring equity, and a natural fit with our vision to build a robust, consumer-centric healthcare portfolio.
• For generations, Vicks has been a trusted part of family care routines, offering comforting relief during cough and cold.

For generations, Vicks has been a trusted part of family care routines, offering comforting relief during cough and cold. Backed by over 125 years of heritage, Vicks VapoRub is formulated to support provide relief from common cold symptoms such as nasal congestion, cough, headache, body ache, and discomfort associated with breathing.

Anwar Zaman, CEO, Welnox, remarked, "Vicks VapoRub is an iconic brand with enduring equity, and a natural fit with our vision to build a robust, consumer-centric healthcare portfolio. We see significant opportunity to build on its solid foundation and unlock new avenues of expansion in Pakistan." Vicks VapoRub will be available in pharmacies throughout Pakistan in the coming weeks. Stay Connected with ProPakistani. Obtain the latest news and stories wherever you prefer. Follow on Google Discover.

Taken together, the developments around welnox Enters into a Licensing Partnership with P& G for Vicks VapoRub point to a situation that is still moving, and the coming days should bring more clarity.